CD38 and metabolic dysfunction-associated steatotic liver disease: Interestingly, we found significantly higher frequencies of CD38+ NK cells (73,00% versus 56,18%, p = 0,0181) and CD38+ CD56dim NK cells (74,87% versus 56,68%, p = 0,0136) in PBMC of NAFLD patients compared to healthy controls (S4B Fig).